• LAST PRICE
    0.3919
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    0.0000 / 0.3919
  • Day Range
    ---
  • 52 Week Range
    Low 0.1340
    High 2.3500
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 0.38
TimeVolumeBCLI
09:32 ET31820.3876
09:36 ET1400.3815
09:38 ET2000.3902
09:43 ET1000.3815
09:45 ET3000.3815
09:48 ET1000.3815
09:50 ET1000.3815
09:52 ET1000.3815
09:54 ET1000.3815
09:56 ET2000.3815
09:57 ET108000.3815
09:59 ET1000.3815
10:01 ET1000.3815
10:03 ET1120.38575
10:06 ET2000.3899
10:10 ET1000.3816
10:14 ET3000.3879
10:15 ET1000.3858
10:21 ET1000.3858
10:26 ET1000.3858
10:28 ET20000.387899
10:30 ET1000.3858
10:33 ET2000.3858
10:37 ET2000.3858
10:44 ET1000.3858
10:48 ET1000.3858
10:51 ET10500.3914
10:53 ET40000.3945
10:55 ET2540.39
11:02 ET10900.387
11:06 ET2000.3876
11:08 ET1000.3877
11:11 ET3000.3944
11:13 ET1000.39
11:15 ET1000.3945
11:18 ET1000.39
11:22 ET1000.39
11:24 ET1020.39
11:26 ET1000.39
11:29 ET11000.3939
11:31 ET1000.3939
11:33 ET1000.39
11:36 ET12690.3939
11:38 ET1000.39
11:42 ET1000.39
11:45 ET1000.39
11:49 ET1000.39
11:51 ET4330.3914
11:54 ET2000.3914
11:56 ET1000.39
12:00 ET2000.3915
12:03 ET2000.39
12:09 ET38080.391
12:12 ET8260.3901
12:14 ET2000.392
12:18 ET3000.392
12:21 ET1000.3917
12:34 ET1000.3918
12:38 ET1000.3918
12:39 ET1000.3918
12:41 ET2000.39185
12:43 ET34550.3919
12:45 ET2000.3918
12:48 ET3000.3918
12:50 ET5000.39185
12:52 ET25000.3918
12:54 ET3000.3918
12:57 ET37000.3923
12:59 ET4000.3923
01:01 ET1000.3918
01:06 ET1000.3918
01:10 ET2000.3918
01:15 ET1000.3924
01:26 ET1000.3918
01:30 ET2000.39265
01:33 ET1000.39265
01:35 ET1000.3924
01:37 ET5000.3929
01:42 ET47000.3924
01:44 ET4000.3926
01:50 ET44000.3926
01:51 ET21000.3926
01:53 ET4000.3926
01:55 ET5670.3926
02:04 ET2000.3926
02:08 ET1000.3924
02:09 ET3450.3924
02:13 ET1000.3919
02:18 ET1000.3919
02:22 ET1000.3919
02:24 ET1000.3919
02:27 ET2000.3928
02:31 ET1000.3919
02:33 ET15240.3928
02:38 ET1000.3928
02:40 ET1000.3928
02:54 ET2000.3924
02:56 ET5440.3923
02:58 ET3280.393
03:00 ET2000.3929
03:05 ET15000.39271
03:09 ET52400.3929
03:14 ET2000.3965
03:18 ET8000.3918
03:20 ET6400.3993
03:25 ET214920.4
03:27 ET383670.4059
03:30 ET12720.403799
03:32 ET1000.3951
03:34 ET1000.3951
03:36 ET1000.3961
03:39 ET11210.40164
03:41 ET2000.3966
03:43 ET50790.403
03:45 ET69750.4179
03:48 ET85210.4063
03:50 ET12610.4063
03:52 ET4000.4063
03:54 ET1000.4063
03:56 ET16850.4088
03:57 ET1000.4088
03:59 ET3000.3919
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesBCLI
Brainstorm Cell Therapeutics Inc
27.5M
-1.2x
---
United StatesCOCP
Cocrystal Pharma Inc
24.9M
-1.5x
---
United StatesABTI
Alterola Biotech Inc
27.3M
-7.5x
---
United StatesRNXT
RenovoRx Inc
27.1M
-1.6x
---
United StatesJAN
Janone Inc
25.3M
-0.6x
---
United StatesLSTA
Lisata Therapeutics Inc
29.3M
-1.4x
---
As of 2024-06-26

Company Information

BrainStorm Cell Therapeutics Inc. is a developer of autologous adult stem cell therapeutics for debilitating neurodegenerative diseases. The neurodegenerative diseases include Amyotrophic Lateral Sclerosis (ALS), Progressive Multiple Sclerosis (PMS), Alzheimer’s disease (AD), and others. The Company is engaged in the clinical development and commercialization of the NurOwn technology platform used to produce autologous mesenchymal stem cells- neurotrophic factors (MSC-NTF) cells. NurOwn leverages cell culture methods to induce autologous bone marrow derived MSCs to secrete high levels of NTFs, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival and improve neurological function. Autologous MSC-NTF cells is for the treatment of ALS. It has completed a phase III trial in ALS. Its wholly owned subsidiary, BrainStorm Cell Therapeutics Ltd., holds exclusive rights to commercialize NurOwn technology.

Contact Information

Headquarters
1325 Avenue Of Americas, 28Th FloorNEW YORK, NY, United States 10019
Phone
201-488-0460
Fax
302-655-5049

Executives

Independent Chairman of the Board
Jacob Frenkel
President, Chief Executive Officer
Chaim Lebovits
Independent Vice Chairman of the Board
Irit Arbel
Chief Financial Officer, Controller
Alla Patlis
Chief Operating Officer, Executive Vice President
Hartoun Hartounian

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$27.5M
Revenue (TTM)
$0.00
Shares Outstanding
70.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.37
EPS
$-0.32
Book Value
$-0.08
P/E Ratio
-1.2x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.